Dynein light chain LC8 regulates syntaphilin-mediated mitochondrial docking in axons.
Mitochondria in the cell bodies of neurons are transported down neuronal processes in response to changes in local energy and metabolic states. Because of their extreme polarity, neurons require specialized mechanisms to regulate mitochondrial transport and retention in axons. Our previous studies using syntaphilin (snph) knock-out mice provided evidence that SNPH targets to axonal mitochondria and controls their mobility through its static interaction with microtubules (MTs). However, the mechanisms regulating SNPH-mediated mitochondrial docking remain elusive. Here, we report an unexpected role for dynein light chain LC8. Using proteomic biochemical and cell biological assays combined with time-lapse imaging in live snph wild-type and mutant neurons, we reveal that LC8 regulates axonal mitochondrial mobility by binding to SNPH, thus enhancing the SNPH-MT docking interaction. Using mutagenesis assays, we mapped a seven-residue LC8-binding motif. Through this specific interaction, SNPH recruits LC8 to axonal mitochondria; such colocalization is abolished when neurons express SNPH mutants lacking the LC8-binding motif. Transient LC8 expression reduces mitochondrial mobility in snph (+/+) but not (-/-) neurons, suggesting that the observed effect of LC8 depends on the SNPH-mediated docking mechanism. In contrast, deleting the LC8-binding motif impairs the ability of SNPH to immobilize axonal mitochondria. Furthermore, circular dichroism spectrum analysis shows that LC8 stabilizes an alpha-helical coiled-coil within the MT-binding domain of SNPH against thermal unfolding. Thus, our study provides new mechanistic insights into controlling mitochondrial mobility through a dynamic interaction between the mitochondrial docking receptor and axonal cytoskeleton.
Chen
Yan-Min
YM
Synaptic Function Section, The Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke-National Institutes of Health, Bethesda, Maryland 20892-3706, USA.
Gerwin
Claudia
C
Sheng
Zu-Hang
ZH
D000818:Animals; D001369:Axons / Q000502:physiology* / Q000648:ultrastructure; D001665:Binding Sites; D002478:Cells, Cultured; D056445:Cytoplasmic Dyneins; D003599:Cytoskeleton / Q000502:physiology; D004398:Dyneins / Q000235:genetics / Q000378:metabolism*; D006624:Hippocampus / Q000502:physiology; D008565:Membrane Proteins; D051379:Mice; D008869:Microtubule-Associated Proteins / Q000235:genetics / Q000378:metabolism*; D008928:Mitochondria / Q000502:physiology*; D009154:Mutation; D018994:Myosin Light Chains / Q000235:genetics / Q000378:metabolism*; D009419:Nerve Tissue Proteins; D009474:Neurons / Q000502:physiology; D011485:Protein Binding; D055550:Protein Stability; D051381:Rats
C514504:Dynll2 protein, mouse; D008565:Membrane Proteins; D008869:Microtubule-Associated Proteins; D018994:Myosin Light Chains; D009419:Nerve Tissue Proteins; C527531:Snph protein, mouse; C486069:Dynll1 protein, rat; D056445:Cytoplasmic Dyneins; D004398:Dyneins